 |
Copyright
The SpicyIP Blog published a guest post concerning copyright protection of musical fountains under the Chinese legislation. The post analyses the approach taken by at least on court in China (the report does not specify the court) regarding dynamic artworks and then compares it with Indian copyright law.
Patents
Juve Patent Blog discussed a recent decision from the Paris First Instance Court, in a battle between the multinational pharmaceutical company MSD (known as Merck & Co in the US) and several producers of generics. The case at hand, which concerns the issue of damages for patent infringement, has been stayed, awaiting the decision of the French Supreme Court on the validity of the supplementary protection certificate (SPC) of MSD’s patent.
With US plans to waive COVID-19 vaccine patents splashed all over the frontpages, the Old Continent is also exploring its options. For a further aspect of IP-related aspects of the COVID-19 pandemic, the Kluwer Patent Blog shared an English translation of the recent French bill proposal concerning granting an ex officio license in the interest of public health..
Trade marks
Facebook announced a joint lawsuit, filed in California together with the fashion brand Gucci, against the head of an international counterfeiting operation. The plaintiffs claim breach of Facebook’s Terms of use and Gucci’s intellectual property rights. This is a first joint lawsuit of this kind concerning the sales of counterfeit goods through social media.
The Fashion Law Blog looked into the Taiwanese registration of the Love Bracelet from Cartier as a three-dimensional trade mark. The 3D shape was registered due to its acquired distinctiveness in that country. According to the post, more trade marks of the kind can now be expected.
Artificial Intelligence
RAILS blog addressed legal implications of using artificial intelligence, including facial recognition technologies (FRT), as an exam proctor. The issue is especially relevant amidst COVID-brought online education. The blog’s analysis is based on the recently revealed proposal for EU Regulation of artificial intelligence.
Around the IP Blogs
Reviewed by Anastasiia Kyrylenko
on
Sunday, May 09, 2021
Rating:
Reviewed by Anastasiia Kyrylenko
on
Sunday, May 09, 2021
Rating:
Follow the IPKat on LinkedIn ![[Guest post] Can AI be considered a PHOSITA? Policy debates in the US and the EU](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggxDO6mW5r4n3-06Af5ckmIaMIhzgPJBoDP8AUsSYXY2zajUQt1ObGVn_GhCgidbG_YDVnybQuJ5XoAjjBG9Ws2xJWDQHNPMrLkn526SWIG371X_Kjt1E8tJmn8Ae_20Phyphenhyphen09JeuUOhhTR3aZE9lMRQlqHGQGcAWGxlo91rrKcLk0AfUjWCvw6RQ/s72-c/Two-cats-eating.jpg)
![[Guest post] Can a trademarked mascot drink, smoke, and spray graffiti under the banner of artistic expression?](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgbyaylrzV0_WRCvj7gUUBCmaRpZYmu5l_yll7jWk32LFKedtZU9fXBnkBocu6wOPN1hNdAcmsMEbripjNMCtI5Lr3VCYfbl9_PJqCuO2Rq4biGkULEo_x_t06S-N5vBIFdAAjcR0L4Q1knvR2ZFxU_F7ZtqRmDrWbWhA7dfSvRjdYwbSx_6oSPvQ/s72-w121-c-h200/Screenshot%202024-04-17%20at%2012.32.14.png)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html